F/M Emerald Life Sciences Innovation ETF (LFSC) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

F/M Emerald Life Sciences Innovation ETF (LFSC) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $103.4M, listed on NASDAQ, carrying a beta of 1.09 to the broader market. LFSC seeks to invest in innovative life sciences companies that are expected to create value and long-term growth. public since 2024-10-21.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for LFSC as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →